Tokyo, Dec. 24 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060175) titled 'Evaluation of the safety of excessive intake of a test product' on Dec. 23.
Study Type:
Interventional
Study Design:
Basic Design - Parallel
Randomization - Randomized
Blinding - Double blind -all involved are blinded
Control - Placebo
Primary Sponsor:
Institute - KAGOME CO., LTD.
Condition:
Condition - Healthy adults
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To evaluate the safety of excessive intake at five times the recommended daily intake of a test product for 4 weeks.
Basic objectives2 - Safety
Intervention:
Interventions/Control_1 - Ingestion of act...